We are international
• health professionals TEXT SIZE   

KOS 2007: The Role of Thalidomide in Myeloma Patients Eligible for High-Dose Therapy
By Michele Cavo, MD
Michele Cavo, MD
Seràgnoli Institute of Hematology and Medical Oncology
Bologna UniversitySchool of Medicine

To view the video full screen, click on the small button next to the volume control in the lower right hand corner.

 related articles